Ethereum News Update: Is the $3,150 Level Ethereum's Final Defense Against a Steeper Drop?
- Ethereum's price dropped 10% to $3,150, testing critical support as market participants assess rebound potential amid mixed institutional and retail demand. - A breakdown below $3,590 triggered accelerated selling, with 138% above-average volume indicating institutional participation in the selloff. - Broader crypto market declines saw Bitcoin fall to $97,000 and $260M in ETH ETF outflows, signaling waning institutional confidence. - Technical indicators show Ethereum failing the 200-day EMA and RSI in d
Ethereum experienced a 10% drop in its price during recent sessions, challenging key support zones as traders assess the chances of a recovery. The cryptocurrency, which has shown significant volatility due to inconsistent interest from both institutions and individual investors, is now hovering around $3,150—a level that market experts believe could provide temporary support. Nevertheless,
The downward momentum intensified after
Technical analysis suggests a cautious bearish outlook. Ethereum has repeatedly failed to surpass its 200-day Exponential Moving Average (EMA), a key resistance for any sustained upward move. The Relative Strength Index (RSI) continues to trend downward, and the Stochastic Oscillator is approaching oversold levels, indicating a possible short-term bounce but not a reversal of the prevailing downtrend.
Despite these immediate hurdles, some market analysts believe that Ethereum’s historical support at $3,150 could help steady prices. “This level has previously attracted buyers,” a crypto strategist commented, though he warned that
Overall, the market remains delicate, with subdued demand from both institutions and retail investors adding to downward pressure.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bitcoin News Update: Crypto Fear Index Drops Sharply—Sign of Surrender or Spark for a Rebound?
- Crypto Fear & Greed Index hit 16, its lowest since February 2025, reflecting extreme bearish sentiment amid Bitcoin and altcoin sell-offs. - Technical indicators and on-chain data show Bitcoin below key moving averages, with 815,000 BTC sold by long-term holders in 30 days. - Analysts highlight $100,000 as critical support, warning further declines if broken, while some see panic-driven buying opportunities. - Technical patterns suggest potential rebounds to $120,000-$126,000 if support holds, contrastin
Bitcoin Updates: Crypto Confidence Wavers—Saylor Calms Fears as Bearish Trends Persist
- Michael Saylor denied rumors of MicroStrategy selling Bitcoin , calming panic after $5.7B in crypto transfers to new wallets triggered market volatility. - Arkham clarified the 43,415 BTC wallet movements as routine custody management, but shares fell 7.2% as investor anxiety over the firm's financial health persisted. - Bitcoin traded near its 50-week SMA at $97,000 amid $870M ETF outflows, with analysts warning of further underperformance against gold and tech stocks in 2025. - Corporate Bitcoin accumu
ZEC +10.72% Surge Attributed to Introduction of Privacy-Oriented Treasury
- Zcash (ZEC) surged 10.72% in 24 hours to $683.14, driven by Cypherpunk Technologies' $50M treasury acquiring 1.25% supply stake. - Winklevoss Capital's $58.88M private placement and institutional backing highlight Zcash's privacy-focused positioning as "encrypted bitcoin ." - Zcash's new Zashi Wallet swap feature and EU regulatory shifts boost demand for privacy-centric assets, while backtests show 30-day excess returns of +22.6% after large price surges. - Cypherpunk's plan to acquire 5% ZEC supply and
LUNA rises by 2.66% despite ongoing legal uncertainties and unstable market conditions
- LUNA rose 2.66% in 24 hours to $0.081, contrasting with 11.76% 7-day and 13.28% 1-month declines. - MoonLake faces class-action lawsuits over alleged misleading claims about its nanobody drug SLK's clinical advantages versus BIMZELX. - Technical analysis shows MLTX's short-term positive momentum after earnings misses, but risks rise beyond one-week holding periods.
